465 related articles for article (PubMed ID: 35844558)
1. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer.
Jin X; Liu Z; Yang D; Yin K; Chang X
Front Immunol; 2022; 13():948647. PubMed ID: 35844558
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of gastric cancer: Past, future perspective and challenges.
Xie J; Fu L; Jin L
Pathol Res Pract; 2021 Feb; 218():153322. PubMed ID: 33422778
[TBL] [Abstract][Full Text] [Related]
3. Current progress and challenges of immunotherapy in gastric cancer: A focus on CAR-T cells therapeutic approach.
Entezam M; Sanaei MJ; Mirzaei Y; Mer AH; Abdollahpour-Alitappeh M; Azadegan-Dehkordi F; Bagheri N
Life Sci; 2023 Apr; 318():121459. PubMed ID: 36720453
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer-Current Treatment Options and Future Perspectives.
Koustas E; Trifylli EM; Sarantis P; Papadopoulos N; Karapedi E; Aloizos G; Damaskos C; Garmpis N; Garmpi A; Papavassiliou KA; Karamouzis MV; Papavassiliou AG
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743107
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Immunomodulation in Gastric Cancer.
Akkanapally V; Bai XF; Basu S
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339311
[TBL] [Abstract][Full Text] [Related]
6. Research progress on the immune microenvironment and immunotherapy in gastric cancer.
Mou P; Ge QH; Sheng R; Zhu TF; Liu Y; Ding K
Front Immunol; 2023; 14():1291117. PubMed ID: 38077373
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in gastric cancer.
Matsueda S; Graham DY
World J Gastroenterol; 2014 Feb; 20(7):1657-66. PubMed ID: 24587645
[TBL] [Abstract][Full Text] [Related]
8. Immune Therapeutics in the Treatment of Advanced Gastric and Esophageal Cancer.
Park R; Williamson S; Kasi A; Saeed A
Anticancer Res; 2018 Oct; 38(10):5569-5580. PubMed ID: 30275174
[TBL] [Abstract][Full Text] [Related]
9. Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023).
Li YN; Xie B; Zhang Y; He MH; Xing Y; Mu DM; Wang H; Guo R
World J Gastroenterol; 2023 Oct; 29(40):5593-5617. PubMed ID: 37970478
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine for advanced cancer immunotherapy.
Diep YN; Kim TJ; Cho H; Lee LP
J Control Release; 2022 Nov; 351():1017-1037. PubMed ID: 36220487
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic advances in gastric cancer.
Yoneda A; Kuroki T; Eguchi S
Surg Today; 2021 Nov; 51(11):1727-1735. PubMed ID: 33590326
[TBL] [Abstract][Full Text] [Related]
12. Challenges of the Immunotherapy: Perspectives and Limitations of the Immune Checkpoint Inhibitor Treatment.
Dobosz P; Stępień M; Golke A; Dzieciątkowski T
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269988
[TBL] [Abstract][Full Text] [Related]
13. Role of Immunotherapy in Advanced Gastroesophageal Cancer.
Terrero G; Lockhart AC
Curr Oncol Rep; 2020 Aug; 22(11):112. PubMed ID: 32803457
[TBL] [Abstract][Full Text] [Related]
14. [Clinical research progress of cell immunity in gastric cancer].
Xu RH; Wu J; Chen M; Zou X; Liu SL
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):321-325. PubMed ID: 31137163
[TBL] [Abstract][Full Text] [Related]
15. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
Wang DK; Zuo Q; He QY; Li B
Front Immunol; 2021; 12():705999. PubMed ID: 34447376
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for Glioblastoma: Current Progress and Challenges.
Yu MW; Quail DF
Front Immunol; 2021; 12():676301. PubMed ID: 34054867
[TBL] [Abstract][Full Text] [Related]
17. The State of Immunotherapy in Hepatobiliary Cancers.
Ilyas FZ; Beane JD; Pawlik TM
Cells; 2021 Aug; 10(8):. PubMed ID: 34440865
[TBL] [Abstract][Full Text] [Related]
18. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
19. Immunology and immunotherapy in gastric cancer.
Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
[TBL] [Abstract][Full Text] [Related]
20. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
